Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1997-04-02 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CREANCES (50710), Manche
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE CREANCES : revenue, balance sheet and financial ratios
PHARMACIE DE CREANCES is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CREANCES (50710),
this company of category PME
shows in 2022 a net income positive of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE CREANCES (SIREN 411860018)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
1 797 735 €
278 890 €
232 176 €
264 454 €
403 052 €
338 541 €
312 637 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE DE CREANCES generates positive net income of 1.8 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 313 k€ -> 1.8 M€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 797 735 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.856%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.366%
Solvency indicators evolution PHARMACIE DE CREANCES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
251.799
274.369
243.74
427.71
435.436
362.949
48.856
Financial autonomy
22.815
21.474
23.895
15.51
15.428
18.135
63.366
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
48.862022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Good-38 pts over 3 years
In 2022, the debt ratio of PHARMACIE DE CREANCES (48.86) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.37%2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Good+46 pts over 3 years
In 2022, the financial autonomy of PHARMACIE DE CREANCES (63.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 61703.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
61703.228
Liquidity indicators evolution PHARMACIE DE CREANCES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
116.294
133.546
171.701
147.657
117.559
141.056
61703.228
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
61703.232022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Excellent+57 pts over 3 years
In 2022, the liquidity ratio of PHARMACIE DE CREANCES (61703.23) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE CREANCES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE DE CREANCES is estimated at
21 153 064 €
(range 14 219 062€ - 31 725 668€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
14219k€21153k€31725k€
21 153 064 €Range: 14 219 062€ - 31 725 668€
NAF 5 année 2022
Valuation method used
Net Income Multiple
1 797 735 €
×
11.8x
=21 153 064 €
Range: 14 219 062€ - 31 725 668€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE CREANCES with other companies in the same sector:
Frequently asked questions about PHARMACIE DE CREANCES
What is the revenue of PHARMACIE DE CREANCES ?
The revenue of PHARMACIE DE CREANCES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE CREANCES profitable?
Yes, PHARMACIE DE CREANCES generated a net profit of 1.8 M€ in 2022.
Where is the headquarters of PHARMACIE DE CREANCES ?
The headquarters of PHARMACIE DE CREANCES is located in CREANCES (50710), in the department Manche.
Where to find the tax return of PHARMACIE DE CREANCES ?
The tax return of PHARMACIE DE CREANCES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE CREANCES operate?
PHARMACIE DE CREANCES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart